Fundraising Fox

Guardant Health

NASDAQ: GH

Redwood City, US · Founded 2011 · Delaware corporation · 12 known investors

guardanthealth.com

Guardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.

BiotechDigital HealthHealthtechMedical Devicesin /guardanthealth@guardanthealth

Founders & leadership

AT
AmirAli TalasazExecutive Officer, Director
WH
Warren HogarthDirector
MW
Michael WileyExecutive Officer
HE
Helmy EltoukhyExecutive Officer, Director
SK
Samir KaulDirector

Investors · 12

Competitors · 10

by search overlap
Ziprecruiter388 shared keywords
Diabetes Prevention Program334 shared keywords
Signant Health315 shared keywordsSignant Health provides eClinical technology and services for clinical trial data collection, including electronic data capture, patient and site data solutions, and scientific and operational support. It serves pharmaceutical sponsors and CROs running global clinical trials to generate high-quality data for trial decisions and regulatory submissions.
Self-Image and Sexuality268 shared keywordsThe National Cancer Institute (NCI) is a U.S. government agency that provides cancer information to patients and the public and funds and supports cancer research, offering resources, funding, and training opportunities for researchers. It serves people affected by cancer and the research community across the United States.
Mapquest211 shared keywordsProvider of geographical information systems and services; acquired by America Online.
American Cancer Society (ACS)197 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
Exact Sciences189 shared keywords
Cowles_Investments_StemCentrx189 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.
Fda189 shared keywords
Labcorp182 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.

Companies competing with Guardant Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$320.4MraisedAug 2017 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samir KaulDirector
  • Michael WileyExecutive Officer
  • Helmy EltoukhyExecutive Officer, Director
  • AmirAli TalasazExecutive Officer, Director
  • Aaref HilalyDirector
Offering amount
$320.4M
Amount sold
$320.4M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$82.8MraisedMar 2016 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samir KaulDirector
  • Michael WileyExecutive Officer
  • Helmy EltoukhyExecutive Officer, Director
  • AmirAli TalasazExecutive Officer, Director
  • Aaref HilalyDirector
Offering amount
$100M
Amount sold
$82.8M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$56MraisedMar 2015 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • AmirAli TalasazExecutive Officer, Director
  • Warren HogarthDirector
  • Michael WileyExecutive Officer
  • Helmy EltoukhyExecutive Officer, Director
  • Samir KaulDirector
Offering amount
$60M
Amount sold
$56M
First sale
Dec 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news